Patent Assignment
Reel/Frame 046748/0608
Assignment of Assignor's Interest
Recorded: 2018-08-08
Pages: 3
Assignors
YLA-HERTTUALA, SEPPO
Executed: 2013-08-19
PARKER, NIGEL
Executed: 2013-08-19
SOPO, MINNA
Executed: 2013-08-19
SALLINEN, HANNA
Executed: 2013-08-19
Assignee
WKD HOLDING OY
MICROKATU 1S, KUOPIO, FINLAND
Covered Property
(1)
Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
Application:
13/969,763 →
Publication:
US 2014/0057851
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 8, 2018
From: WKD HOLDING OY
To: TRIZELL LTD.
Reel/Frame 046585/0156 →
Security Interest
Nov 19, 2020
From: TRIZELL LTD.
To: PHARMACEUTICAL PATENT ATTORNEYS, LLC
Reel/Frame 054775/0546 →
Release of Security Interest
Jan 31, 2022
From: PHARMACEUTICAL PATENT ATTORNEYS, LLC
To: TRIZELL LTD., F/K/A FINVECTOR LTD. F/K/A ARK THERAPEUTICS LTD.
Reel/Frame 058826/0044 →